Acute bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: andrological implications

• Published in: Andrologia Vol. 40; no. 2; pp. 105 - 112
• Main Authors: Weidner, W., Wagenlehner, F. M. E., Marconi, M., Pilatz, A., Pantke, K. H. P., Diemer, T.
• Format: Journal Article Conference Proceeding
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.04.2008; Blackwell
• Subjects: Acute Disease; Androgens - physiology; Anti-Bacterial Agents - therapeutic use; Biological and medical sciences; Birth control; Chronic Disease; Chronic pelvic pain syndrome; Gynecology. Andrology. Obstetrics; Humans; infection; Male; Male genital diseases; male infertility; Medical sciences; Nephrology. Urinary tract diseases; Pelvic Pain - diagnosis; Pelvic Pain - drug therapy; prostatitis; Prostatitis - diagnosis; Prostatitis - drug therapy; Sterility. Assisted procreation; Syndrome; Urinary system involvement in other diseases. Miscellaneous; Urinary tract. Prostate gland; Infection; Chronic; Reproduction; Urinary system disease; Chronic pelvic pain syndrome- infection-male infertility-prostatitis; Prostate disease; Bacteriosis; Male sterility; Prostatitis; Male genital diseases; Pelvic pain; Male genital system
• ISSN: 0303-4569; 1439-0272
• DOI: 10.1111/j.1439-0272.2007.00828.x

Summary There is a consensus on the diagnostic management of bacterial prostatitis (acute and chronic). In chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) the diagnostic approach remains unclear, because inflammatory and noninflammatory CP/CPPS might be one entity with varying findings over time. The WHO definition of male accessory gland infection does not differentiate between prostatitis, epididymitis, and other inflammatory alterations of the urethral compartment. The definition therefore cannot be further accepted as a rational tool for the diagnosis of prostatitis and related diseases in urological andrology. Therapy in infectious prostatitis is standardised and antibiotics are the primary agents. Andrological implications are well defined, side‐effects are minimal. CP/CPPS therapy has the goal to reduce pelvic pain. However, treatment regimens are not as standardised. Andrological side‐effects are well defined and mainly due to the functional background of these agents.